drugset

drugset / Trial / NCT00356005

Azithromycin Combination Therapy for the Treatment of Uncomplicated Falciparum Malaria in Bangladesh

NCT00356005 ↗

Phase 2 Completed 228 enrolled Medical University of Vienna Armed Forces Research Institute of Medical Sciences, Thailand · collab International Centre for Diarrhoeal Disease Research, Bangladesh · collab

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the efficacy of azithromycin combination therapy with artesunate for the treatment of uncomplicated falciparum malaria in Bangladesh.

Timeline

Start: 2006-08
Primary completion: 2007-08
Completion: —

Publications

Thriemer K, Starzengruber P, Khan WA, Haque R, Marma AS, Ley B, Vossen MG, Swoboda P, Akter J, Noedl H. Azithromycin combination therapy for the treatment of uncomplicated falciparum malaria in Bangladesh: an open-label randomized, controlled clinical trial. J Infect Dis. 2010 Aug 15;202(3):392-8. doi: 10.1086/653710.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Artesunate	Small molecule	4 mg/kg	—
Subject	Azithromycin	Small molecule	30 mg/kg	—

Indications